Business Context and Reporting Period
This Form 8-K was filed by Cardio Diagnostics Holdings, Inc. on November 22, 2023, reporting events occurring on November 20, 2023. The Company is an emerging growth company incorporated in Delaware, with its common stock (CDIO) and warrants (CDIOW) listed on The Nasdaq Capital Market.
Key Financial Metrics
- Stockholders' Equity (Q3 2023): $2,287,731 as of September 30, 2023 (reported in Form 10-Q).
- Stockholders' Equity (Post-Conversion): $4,044,689.85 as of October 31, 2023, following the conversion of convertible debentures.
- Nasdaq Minimum Requirement: $2,500,000 in stockholders' equity.
- Debt Activity: On October 31, 2023, YA II PN, LTD. fully converted its convertible debentures into common stock.
- Revenue/Profit/Cash Flow: The filing text does not provide specific values for revenue, net income, or cash flow for the current period.
Material Changes
The Company received a notice from Nasdaq on November 20, 2023, stating it was not in compliance with the minimum stockholders' equity requirement based on its September 30, 2023, financials ($2,287,731 vs. the $2,500,000 threshold). Additionally, the Company did not meet alternative listing standards regarding market value or net income.
However, a material positive change occurred on October 31, 2023, when the conversion of Yorkville Advisors' debentures increased stockholders' equity to approximately $4.04 million, exceeding the Nasdaq requirement. The Company asserts it has regained compliance since that date.
Outlook, Risks, and Management Commentary
- Listing Status: The Nasdaq notice has no immediate effect on the listing of the Company's securities, but Nasdaq will continue to monitor compliance.
- Delisting Risk: If the Company fails to evidence compliance with the equity requirement in its next periodic report, it may be subject to delisting.
- Management Action: The Company is evaluating various courses of action to maintain compliance, including seeking financing options.
- Forward-Looking Statements: The filing includes standard disclaimers regarding future intentions to maintain compliance, noting these are subject to risks and uncertainties.
Investor Verification Checklist
- Verify the Company's stockholders' equity in the upcoming Form 10-Q or 10-K to confirm continued compliance with the $2.5 million Nasdaq threshold.
- Monitor for any further communications from Nasdaq regarding the Company's listing status.
- Review the Company's progress on seeking additional financing options mentioned in the filing.
- Check the latest Form 10-K and 10-Q for detailed revenue, net income, and cash flow figures not included in this 8-K.